This inventor holds 2 USPTO granted patents. Top assignees: Kitasato Kenkyushio, Takeda Chemical Corporation, Takeda Chemical Ind., Ltd.. Active years: 1995-1998.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 1 
1 out of 2 
1 out of 8 Years Active: 1995-1998
Title: **Shigeharu Tanayama: A Pioneer in Gastrointestinal Pharmaceuticals**
Introduction
Shigeharu Tanayama, an esteemed inventor based in Osaka, Japan, has made significant contributions to the field of pharmaceuticals, specifically in gastrointestinal function promoting agents. With a remarkable portfolio of two patents, he has established himself as a notable figure in innovation.
Latest Patents
Tanayama's latest innovations revolve around novel 15-hydroxy 6,9-hemiacetal erythromycin compounds. These patents disclose several groundbreaking aspects:
1. A structurally novel 6,9-hemiacetal-erythromycin derivative featuring a hydroxyl group at the 14- and/or 15-positions, recognized for its excellent gastrointestinal function promoting effect and low toxicity.
2. A detailed process for preparing this derivative involves reacting a 6,9-hemiacetal-erythromycin derivative or its salt with an organism-derived oxidase.
3. The creation of a gastrointestinal function promoting agent that incorporates the 6,9-hemiacetal-erythromycin derivative having a hydroxyl group.
Furthermore, another similar patent highlights the same structural innovations and processes, emphasizing Tanayama's commitment to enhancing gastrointestinal health through innovative pharmaceutical compounds.
Career Highlights
Tanayama has had a noteworthy career, working with prominent companies such as Takeda Chemical Industries, Ltd. and Kitasato Kenkyushio. His roles in these organizations have allowed him to translate his innovative ideas into practical and impactful pharmaceuticals.
Collaborations
Throughout his career, Tanayama has collaborated with esteemed colleagues like Setsuo Harada and Yasunori Funabashi. These partnerships have significantly enhanced the innovation process, fostering an environment ripe for breakthrough developments in pharmaceutical research.
Conclusion
Shigeharu Tanayama stands out in the realm of pharmaceutical innovation. His patents and collaborations underscore his dedication to improving gastrointestinal health through novel compounds. As he continues to contribute to the field, his work may lead to further advancements in the healthcare sector.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile